loadpatents
Patent applications and USPTO patent grants for Arikawa; Yuka.The latest application filed is for "cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer".
Patent | Date |
---|---|
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer App 20210332071 - Siddiqui-Jain; Adam ;   et al. | 2021-10-28 |
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same Grant 11,040,038 - Warner , et al. June 22, 2 | 2021-06-22 |
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant 11,034,710 - Siddiqui-Jain , et al. June 15, 2 | 2021-06-15 |
Cdk9 Inhibitors And Polymorphs Thereof For Use As Agents For Treatment Of Cancer App 20200255462 - Kind Code | 2020-08-13 |
Methods For Treating Diseases Associated With Abnormal Acvr1 Expression And Acvr1 Inhibitors For Use In The Same App 20200085823 - Warner; Steven L. ;   et al. | 2020-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.